机构ID,机构名称,公告日期,开始日期,截止日期,报告年度,合并类型,报表来源,销售商品、提供劳务收到的现金（元）,收到的税费返还,收到其他与经营活动有关的现金,经营活动现金流入小计,购买商品、接受劳务支付的现金,支付给职工以及为职工支付的现金,支付的各项税费,支付其他与经营活动有关的现金,经营活动现金流出小计,经营活动产生的现金流量净额,收回投资收到的现金,取得投资收益收到的现金,处置固定资产、无形资产和其他长期资产收回的现金净额,处置子公司及其他营业单位收到的现金净额,收到其他与投资活动有关的现金,投资活动现金流入小计,购建固定资产、无形资产和其他长期资产支付的现金,投资支付的现金,质押贷款净增加额,取得子公司及其他营业单位支付的现金净额,支付其他与投资活动有关的现金,投资活动现金流出小计,投资活动产生的现金流量净额,吸收投资收到的现金,取得借款收到的现金,发行债券收到的现金,收到其他与筹资活动有关的现金,筹资活动现金流入小计,偿还债务支付的现金,分配股利、利润或偿付利息支付的现金,支付其他与筹资活动有关的现金,筹资活动现金流出小计,筹资活动产生的现金流量净额,四、汇率变动对现金的影响,四(2)、其他原因对现金的影响,五、现金及现金等价物净增加额,期初现金及现金等价物余额,期末现金及现金等价物余额,附注：,1、将净利润调节为经营活动现金流量：,净利润,加：资产减值准备,固定资产折旧、油气资产折耗、生产性生物资产折旧,无形资产摊销,长期待摊费用摊销,处置固定资产、无形资产和其他长期资产的损失,固定资产报废损失,公允价值变动损失,财务费用,投资损失,递延所得税资产减少,递延所得税负债增加,存货的减少,经营性应收项目的减少,经营性应付项目的增加,其他,经营活动产生的现金流量净额2,2、不涉及现金收支的重大投资和筹资活动：,债务转为资本,一年内到期的可转换公司债券,融资租入固定资产,3、现金及现金等价物净变动情况：,现金的期末余额,减：现金的期初余额,加：现金等价物的期末余额,减：现金等价物的期初余额,加：其他原因对现金的影响2,现金及现金等价物净增加额2,客户存款和同业存放款项净增加额,向中央银行借款净增加额,向其他金融机构拆入资金净增加额,收到原保险合同保费取得的现金,收到再保险业务现金净额,保户储金及投资款净增加额,处置以公允价值计量且其变动计入当期损益的金融资产净增加额,收取利息、手续费及佣金的现金,拆入资金净增加额,回购业务资金净增加额,客户贷款及垫款净增加额,存放中央银行和同业款项净增加额,支付原保险合同赔付款项的现金,支付利息、手续费及佣金的现金,支付保单红利的现金,其中：子公司吸收少数股东投资收到的现金,其中：子公司支付给少数股东的股利、利润,投资性房地产的折旧及摊销
300519,新光药业,2016-06-06,2016-01-01,2016-03-31,2016-03-31,合并本期,招募说明书,111272167.28,0.0,1441391.91,112713559.19,10268460.73,8875744.99,21216402.44,7956515.9,48317124.06,64396435.13,,0.0,,,0.0,,4766567.47,0.0,,,0.0,4766567.47,-4766567.47,0.0,,,0.0,,,11297.22,0.0,11297.22,-11297.22,,,59618570.44,175362149.4,234980719.84,,,,,0.0,,0.0,,,,0.0,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
300519,新光药业,2016-08-02,2016-01-01,2016-06-30,2016-06-30,合并本期,定期报告,161318402.15,634678.08,1942655.93,163895736.16,26895972.8,16126509.46,34696434.68,22534512.58,100253429.52,63642306.64,,240000.0,,,,240000.0,6828125.25,,,,,6828125.25,-6588125.25,227000000.0,,,,227000000.0,,23819.43,5195000.0,5218819.43,221781180.57,,,278835361.96,175362149.4,454197511.36,,,57046159.75,-527504.9,2885277.29,145311.6,,,,,23819.43,-240000.0,81404.54,,-978975.82,4149697.02,1057117.73,,63642306.64,,,,,,454197511.36,175362149.4,,,,278835361.96,,,,,,,,,,,,,,,,,,
300519,新光药业,2016-10-28,2016-01-01,2016-09-30,2016-09-30,合并本期,定期报告,228518520.23,634678.08,3423044.76,232576243.07,41779400.31,24644458.97,44960403.8,34027874.91,145412137.99,87164105.08,,339833.28,,,,339833.28,17226557.69,110000000.0,,,,127226557.69,-126886724.41,227000000.0,,,,227000000.0,,36341.64,14045000.0,14081341.64,212918658.36,,,173196039.03,175362149.4,348558188.43,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
300519,新光药业,2017-04-18,2016-01-01,2016-12-31,2016-12-31,合并本期,定期报告,295455734.17,634678.08,8965031.07,305055443.32,42771452.04,33129370.77,60304078.92,47665661.13,183870562.86,121184880.46,,706749.8,,,,706749.8,22269924.33,,,,150000000.0,172269924.33,-171563174.53,227000000.0,,,,227000000.0,1000000.0,45601.36,14305000.0,15350601.36,211649398.64,,,161271104.57,175362149.4,336633253.97,,,118958793.02,168044.51,5737416.58,290623.7,0.0,18556.45,0.0,0.0,45188.86,-706749.8,-21867.44,0.0,-10390190.67,-2650076.68,9735141.93,,121184880.46,,0.0,0.0,0.0,,336633253.97,175362149.4,0.0,0.0,,161271104.57,,,,,,,,,,,,,,,,,,
300519,新光药业,2017-04-26,2017-01-01,2017-03-31,2017-03-31,合并本期,定期报告,95553159.93,,1650740.52,97203900.45,11975516.06,9201882.32,18291899.69,5420407.69,44889705.76,52314194.69,,905013.7,,,90000000.0,90905013.7,2760139.11,,,,90000000.0,92760139.11,-1855125.41,,,,,,,,,,,,,50459069.28,336633253.97,387092323.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
300519,新光药业,2017-08-15,2017-01-01,2017-06-30,2017-06-30,合并本期,定期报告,149433727.89,,2159118.73,151592846.62,20183193.24,16320010.15,29965571.25,21756261.86,88225036.5,63367810.12,,1976678.09,,,130000000.0,131976678.09,5090055.62,,,,168000000.0,173090055.62,-41113377.53,,,,,,,10000000.0,1000000.0,11000000.0,-11000000.0,,,11254432.59,336633253.97,347887686.56,,,51386749.19,-613998.21,2873815.97,143920.7,0.0,0.0,0.0,0.0,0.0,-1878634.93,110829.61,0.0,1478330.65,17218369.16,-7351572.02,,63367810.12,,0.0,0.0,0.0,,347887686.56,336633253.97,0.0,0.0,,11254432.59,,,,,,,,,,,,,,,,,,
